Bacterial specialized metabolites are a proven source of antibiotics and cancer therapeutics, but whether we have sampled all the secondary metabolite chemical diversity of cultivated bacteria is not known. We analysed ~ 170,000 bacterial genomes and ~ 47,000 metagenome assembled genomes (MAGs) using a modified BiG-SLiCE and the new clust-o-matic algorithm. We found that only 3% of the natural products potentially encoded in bacterial genomes have been experimentally characterized. We show that the variation of secondary metabolite biosynthetic diversity drops significantly on a genus level, identifying it as an appropriate taxonomic rank for comparison. Equal comparison of genera based on Relative Evolutionary Distance revealed that Strep...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Access to genome sequence data has challenged traditional natural product discovery paradigms by rev...
Bacterial specialized metabolites are a proven source of antibiotics and cancer therapeutics, but wh...
Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as...
Microorganisms are a rich source of bioactives; however, chemical identification is a major bottlene...
Natural products from microbes have provided humans with beneficial antibiotics for millennia. Howev...
Abstract Background Genome mining tools have enabled us to predict biosynthetic gene clusters that m...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Antibiotic development based on natural products has faced a long lasting decline since the 1970s, w...
Microbial natural products are a tremendous source of new bioactive chemical entities for drug disco...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Streptomyces bacteria have a remarkable capacity to biosynthesize natural products. The discovery of...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Access to genome sequence data has challenged traditional natural product discovery paradigms by rev...
Bacterial specialized metabolites are a proven source of antibiotics and cancer therapeutics, but wh...
Bacterial secondary metabolites have been studied for decades for their usefulness as drugs, such as...
Microorganisms are a rich source of bioactives; however, chemical identification is a major bottlene...
Natural products from microbes have provided humans with beneficial antibiotics for millennia. Howev...
Abstract Background Genome mining tools have enabled us to predict biosynthetic gene clusters that m...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Antibiotic development based on natural products has faced a long lasting decline since the 1970s, w...
Microbial natural products are a tremendous source of new bioactive chemical entities for drug disco...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Streptomyces bacteria have a remarkable capacity to biosynthesize natural products. The discovery of...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
The prevalence of antibiotic resistance and the decrease in novel antibiotic discovery in recent yea...
Access to genome sequence data has challenged traditional natural product discovery paradigms by rev...